Cardio Diagnostics Holdings, Inc. Prepaid Expense and Other Assets, Current
Cardio Diagnostics Holdings, Inc. (CDIO) had Prepaid Expense and Other Assets, Current of $569.36 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-07
- 2026-06-30: Prepaid Expense and Other Assets, Current $569.36K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $663.32K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $801.95K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $561.03K.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $569.36K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $663.32K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $801.95K 10-Q · filed 2026-08-07 |
| 2025-09-30 | $561.03K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $723.92K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $837.22K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $944.68K 10-K · filed 2026-03-13 |
| 2024-09-30 | $630.48K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $820.89K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.01M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $1.48M 10-K · filed 2025-03-20 |
| 2023-09-30 | $892.30K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.21M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.43M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.77M 10-K · filed 2024-04-01 |
| 2021-12-31 | $39.84K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |